3-Cyanopyridine Market to Reach 400 Million USD by 2025, Anchor for Vitamin B3 and Agrochemical Industries
Date : 2025-12-17
Reading : 370
HDIN Research, a leading provider of chemical market intelligence, has announced the release of its latest analysis on the 3-Cyanopyridine market. The report underscores the critical role of this intermediate in the global nutrition and pharmaceutical supply chains, projecting steady growth driven by the expanding Vitamin B3 sector and specialized agrochemical applications.
Market Overview and Growth Trajectory
According to HDIN Research data, the global market revenue for 3-Cyanopyridine in 2025 is estimated to range between 200 million and 400 million USD. Fueled by consistent demand in human and animal nutrition, as well as high-value crop protection chemicals, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 2.7% to 4.7% through 2030.
3-Cyanopyridine (CAS No. 100-54-9), also known as Nicotinonitrile, is synthesized primarily from 3-Methylpyridine. It serves as a vital building block in organic synthesis, linking upstream petrochemicals to downstream life science industries.
Diverse Application Spectrum
The report highlights that the production of Niacinamide and Niacin (Vitamin B3) remains the dominant consumption channel for 3-Cyanopyridine. However, industrial diversification is widening its usage:
Agrochemicals: It is a key intermediate for insecticides such as Pymetrozine and Imidacloprid.
Pharmaceutical Derivatives: 3-Cyanopyridine is processed into 2-Chloro Nicotinic Acid, a crucial intermediate for various drugs including Flunixin (anti-inflammatory), Nevirapine (HIV reverse transcriptase inhibitor), and Pranoprofen.
Advanced Agrochemical Intermediates: 2-Chloro Nicotinic Acid derived from 3-Cyanopyridine is also used to synthesize herbicides and fungicides like Nicosulfuron.
Specialty Chemicals: It is used to produce 3-Aminomethylpyridine, an intermediate for the rodenticide Vacor.
Supply Chain and Capacity Analysis
HDIN Research identifies a distinct split in business models among major manufacturers, ranging from vertically integrated giants to pure-play merchant suppliers.
Integrated Production Models:
Brother Enterprises Holding Co. Ltd. operates a production capacity of 10,000 tons. The company utilizes a captive consumption model, using its entire output internally to support its Vitamin B3 manufacturing lines.
Anhui Redpont Biotechnology Co. Ltd. (a subsidiary of Nanjing Red Sun Group) has established a fully vertical supply chain. The company controls the process from 3-Methylpyridine to 3-Cyanopyridine, culminating in a 20,000-ton Vitamin B3 production capacity. This integration shields the company from upstream volatility.
Merchant Market Suppliers:
Nantong Liyang Chemical Co. Ltd. (a subsidiary of Nantong Acetic Acid Co. Ltd.) operates a 10,000-ton capacity facility. Unlike integrated players, Nantong Liyang focuses on the merchant market, with its entire output designated for external sales to pharmaceutical and agrochemical clients.
Other significant players influencing the global trade flow include Jubilant Ingrevia Limited, Resonance Specialties Limited, Shandong Hongda Biological Technology, Yuki Gosei Kogyo, and Koei Chemical.
HDIN Research notes that the market structure is stabilizing around these key players, with a clear trend toward vertical integration to secure margins in the Vitamin B3 value chain. Meanwhile, independent suppliers play a crucial role in supporting the specialized pharmaceutical and agrochemical derivative markets.
About HDIN Research
HDIN Research is a trusted source for market data and strategic consulting in the chemical and materials sectors. We assist stakeholders in navigating complex industrial landscapes through precise data analysis and trend forecasting.
Media Contact:
Company Name: HDIN Research
Website: www.hdinresearch.com
Email: sales@hdinresearch.com
Market Overview and Growth Trajectory
According to HDIN Research data, the global market revenue for 3-Cyanopyridine in 2025 is estimated to range between 200 million and 400 million USD. Fueled by consistent demand in human and animal nutrition, as well as high-value crop protection chemicals, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 2.7% to 4.7% through 2030.
3-Cyanopyridine (CAS No. 100-54-9), also known as Nicotinonitrile, is synthesized primarily from 3-Methylpyridine. It serves as a vital building block in organic synthesis, linking upstream petrochemicals to downstream life science industries.
Diverse Application Spectrum
The report highlights that the production of Niacinamide and Niacin (Vitamin B3) remains the dominant consumption channel for 3-Cyanopyridine. However, industrial diversification is widening its usage:
Agrochemicals: It is a key intermediate for insecticides such as Pymetrozine and Imidacloprid.
Pharmaceutical Derivatives: 3-Cyanopyridine is processed into 2-Chloro Nicotinic Acid, a crucial intermediate for various drugs including Flunixin (anti-inflammatory), Nevirapine (HIV reverse transcriptase inhibitor), and Pranoprofen.
Advanced Agrochemical Intermediates: 2-Chloro Nicotinic Acid derived from 3-Cyanopyridine is also used to synthesize herbicides and fungicides like Nicosulfuron.
Specialty Chemicals: It is used to produce 3-Aminomethylpyridine, an intermediate for the rodenticide Vacor.
Supply Chain and Capacity Analysis
HDIN Research identifies a distinct split in business models among major manufacturers, ranging from vertically integrated giants to pure-play merchant suppliers.
Integrated Production Models:
Brother Enterprises Holding Co. Ltd. operates a production capacity of 10,000 tons. The company utilizes a captive consumption model, using its entire output internally to support its Vitamin B3 manufacturing lines.
Anhui Redpont Biotechnology Co. Ltd. (a subsidiary of Nanjing Red Sun Group) has established a fully vertical supply chain. The company controls the process from 3-Methylpyridine to 3-Cyanopyridine, culminating in a 20,000-ton Vitamin B3 production capacity. This integration shields the company from upstream volatility.
Merchant Market Suppliers:
Nantong Liyang Chemical Co. Ltd. (a subsidiary of Nantong Acetic Acid Co. Ltd.) operates a 10,000-ton capacity facility. Unlike integrated players, Nantong Liyang focuses on the merchant market, with its entire output designated for external sales to pharmaceutical and agrochemical clients.
Other significant players influencing the global trade flow include Jubilant Ingrevia Limited, Resonance Specialties Limited, Shandong Hongda Biological Technology, Yuki Gosei Kogyo, and Koei Chemical.
HDIN Research notes that the market structure is stabilizing around these key players, with a clear trend toward vertical integration to secure margins in the Vitamin B3 value chain. Meanwhile, independent suppliers play a crucial role in supporting the specialized pharmaceutical and agrochemical derivative markets.
About HDIN Research
HDIN Research is a trusted source for market data and strategic consulting in the chemical and materials sectors. We assist stakeholders in navigating complex industrial landscapes through precise data analysis and trend forecasting.
Media Contact:
Company Name: HDIN Research
Website: www.hdinresearch.com
Email: sales@hdinresearch.com